Caris Life Sciences, Inc. (CAI) — Stock Score Summary

Caris Life Sciences, Inc. (CAI) has a MoatMap StockRank of 24/100 based on Quality (65/100), Value (23/100), and Momentum (23/100) factor scores. The current signal is SELL. Caris Life Sciences is a precision medicine and molecular profiling company. While operating in an innovative space, it is not a CDMO, suffers from high cash burn, and lacks the established cash flows and high ROIC required for our concentrated portfolio.

Caris Life Sciences, Inc. is a precision oncology company offering molecular profiling services and AI-driven diagnostics for cancer, guiding personalized treatment decisions. Its proprietary AI platform (Caris AI) and extensive real-world clinical data set allow for deep insights into tumor biology, differentiating its diagnostic capabilities. Caris is a pioneer in precision medicine, advancing cancer diagnostics and therapeutic selection through advanced molecular profiling and artificial intelligence.

Key Financial Metrics

Price$16.96
Market Cap$4.7B
P/E (Forward)47.25
Price/Book8.23
Return on Equity28.4%
Return on Invested Capital-1.1%
Debt/Equity72.61
Gross Margin68.9%
Operating Margin2.4%
Revenue Growth78.8%
Free Cash Flow$102M

Caris Life Sciences, Inc. operates in the Biotechnology industry, part of the Healthcare sector (United States).

Frequently Asked Questions

What is Caris Life Sciences, Inc.’s (CAI) StockRank?
MoatMap’s StockRank for Caris Life Sciences, Inc. (CAI) is 24/100, with a Sell signal. It is a composite of Quality (65), Value (23), and Momentum (23) factor ranks across MoatMap’s 19,000+ stock universe.
Does Caris Life Sciences, Inc. have an economic moat?
Caris Life Sciences, Inc. (CAI) has a Quality factor score of 65/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Caris Life Sciences, Inc. a buy, hold, or sell?
MoatMap’s current signal for Caris Life Sciences, Inc. (CAI) is Sell, based on a StockRank of 24/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Caris Life Sciences, Inc. in?
Caris Life Sciences, Inc. (CAI) operates in the Healthcare sector, specifically the Biotechnology industry (United States).
Browse all ranked stocksCAI deep dive reportAI ChampionsHow we score stocksSense-check another stock